Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| B2M or CIITA knockdown decreased the alloimmune response of dental pulp stem cells: an in vitro study. | Stem Cell Res Ther | 2024 | 39538338 | PubTator, text mining | PubMed |
| Investigating the role of disulfidptosis related genes in radiotherapy resistance of lung adenocarcinoma. | Front Med (Lausanne) | 2024 | 39507711 | PubTator, text mining | PubMed |
| mRNA-seq-based analysis predicts: AEG-1 is a therapeutic target and immunotherapy biomarker for pan-cancer, including OSCC. | Front Immunol | 2024 | 39483471 | PubTator, text mining | PubMed |
| Unveiling signaling pathways inducing MHC class II expression in neutrophils. | Front Immunol | 2024 | 39403371 | PubTator, text mining | PubMed |
| NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression. | J Hematol Oncol | 2024 | 39402629 | PubTator, text mining | PubMed |
| Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL. | Hemasphere | 2024 | 39380845 | PubTator, text mining | PubMed |
| Multi-omics profiling and experimental verification of tertiary lymphoid structure-related genes: molecular subgroups, immune infiltration, and prognostic implications in lung adenocarcinoma. | Front Immunol | 2024 | 39364403 | PubTator, text mining | PubMed |
| Allogeneic and other innovative chimeric antigen receptor platforms. | Clin Hematol Int | 2024 | 39351308 | PubTator, text mining | PubMed |
| Differential modulation of mutant CALR and JAK2 V617F-driven oncogenesis by HLA genotype in myeloproliferative neoplasms. | Front Immunol | 2024 | 39351227 | PubTator, text mining | PubMed |
| Class II Transactivator Gene (CIITA) Variants Associated with Bare Lymphocyte Syndrome II in a Female Sudanese Patient. | Appl Clin Genet | 2024 | 39347515 | PubTator, text mining | PubMed |
| PDCD4 deficiency in hepatocytes exacerbates nonalcoholic steatohepatitis through enhanced MHC class II transactivator expression. | Metabolism | 2024 | 39342987 | PubTator, text mining | PubMed |
| A Circular Network of Coregulated L-Threonine and L-Tryptophan Metabolism Dictates Acute Lower Limb Ischemic Injury. | Int J Med Sci | 2024 | 39310266 | PubTator, text mining | PubMed |
| A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells. | Viruses | 2024 | 39205150 | PubTator, text mining | PubMed |
| KDM6A regulates immune response genes in multiple myeloma. | Blood | 2024 | 39046770 | PubTator, text mining | PubMed |
| Erratum to 'Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction' [Clin Mol Hepatol 2024;30:539-560]. | Clin Mol Hepatol | 2024 | 39044466 | PubTator, text mining | PubMed |
| A Ménage à trois: NLRC5, immunity, and metabolism. | Front Immunol | 2024 | 39035010 | PubTator, text mining | PubMed |
| Reply to correspondence on "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction". | Clin Mol Hepatol | 2024 | 39019083 | PubTator, text mining | PubMed |
| MHC Class II Deficiency: Clinical, Immunological, and Genetic Insights in a Large Multicenter Cohort. | J Allergy Clin Immunol Pract | 2024 | 38996837 | PubTator, text mining | PubMed |
| Correspondence on editorial regarding "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction". | Clin Mol Hepatol | 2024 | 38978449 | PubTator, text mining | PubMed |
| Class II transactivator restricts viral replication, extending its effect to HBV: Editorial on "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction". | Clin Mol Hepatol | 2024 | 38957141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=8